Pharmacogenetic Data Integration Into Labeling To Be Discussed By Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
Clinical Pharmacology Subcommittee will meet Nov. 14-15 on several topics including pharmacogenetic data integration and the biomarker-surrogate endpoint project of FDA's "Critical Path" initiative.